Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 997

1.

Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in Ang II-challenged vascular endothelium.

Han J, Shi X, Du Y, Shi F, Zhang B, Zheng Z, Xu J, Jiang L.

Phytother Res. 2019 Jan 10. doi: 10.1002/ptr.6271. [Epub ahead of print]

PMID:
30632210
2.

Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.

Liu Y, Liu Z, Wei M, Hu M, Yue K, Bi R, Zhai S, Pi Z, Song F, Liu Z.

Food Funct. 2019 Jan 9. doi: 10.1039/c8fo02067a. [Epub ahead of print]

PMID:
30623955
3.

Chemical constituents isolated from stems of Schisandra chinensis and their antifeedant activity against Tribolium castaneum.

Guo SS, Pang X, Wang Y, Geng ZF, Cao JQ, Liang JY, Deng ZW, Du SS.

Nat Prod Res. 2019 Jan 9:1-7. doi: 10.1080/14786419.2018.1547291. [Epub ahead of print]

PMID:
30623674
4.

Characterization of lignans in Schisandra chinensis oil with a single analysis process by UPLC-Q/TOF-MS.

Gao Y, Wu S, Cong R, Xiao J, Ma F.

Chem Phys Lipids. 2019 Jan 2;218:158-167. doi: 10.1016/j.chemphyslip.2018.12.012. [Epub ahead of print]

PMID:
30610837
5.

Evaluation of neuroactive effects of ethanol extract of Schisandra chinensis, Schisandrin, and Schisandrin B and determination of underlying mechanisms by zebrafish behavioral profiling.

Wang JW, Liang FY, Ouyang XS, Li PB, Pei Z, Su WW.

Chin J Nat Med. 2018 Dec;16(12):916-925. doi: 10.1016/S1875-5364(18)30133-X.

PMID:
30595216
6.

Impact of dibenzocyclooctadiene lignans from Schisandra chinensis on the redox status and activation of human innate immune system cells.

Kortesoja M, Karhu E, Olafsdottir ES, Freysdottir J, Hanski L.

Free Radic Biol Med. 2019 Feb 1;131:309-317. doi: 10.1016/j.freeradbiomed.2018.12.019. Epub 2018 Dec 19.

7.

Schisandrin B elicits the Keap1-Nrf2 defense system via carbene reactive metabolite which is less harmful to mice liver.

Feng S, Qiu B, Zou L, Liu K, Xu X, Zhu H.

Drug Des Devel Ther. 2018 Nov 23;12:4033-4046. doi: 10.2147/DDDT.S176561. eCollection 2018.

8.

Schisandra Chinensis Lignans Suppresses the Production of Inflammatory Mediators Regulated by NF-κB, AP-1, and IRF3 in Lipopolysaccharide-Stimulated RAW264.7 Cells.

Luo G, Cheng BC, Zhao H, Fu XQ, Xie R, Zhang SF, Pan SY, Zhang Y.

Molecules. 2018 Dec 14;23(12). pii: E3319. doi: 10.3390/molecules23123319.

9.

Anticancer activity of gomisin J from Schisandra chinensis fruit.

Jung S, Moon HI, Kim S, Quynh NTN, Yu J, Sandag Z, Le DT, Lee H, Lee H, Lee MS.

Oncol Rep. 2019 Jan;41(1):711-717. doi: 10.3892/or.2018.6850. Epub 2018 Nov 2.

PMID:
30542721
10.

Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway.

Han J, Shi X, Zheng Z, Zhang B, Shi F, Jiang L, Xu J.

Drug Des Devel Ther. 2018 Nov 22;12:3985-3997. doi: 10.2147/DDDT.S184245. eCollection 2018.

11.

Effects of crushed Schisandra Fruit on the content of lignans in Kampo decoction.

Atsumi T, Yokoyama Y, Yokogawa T, Makino T, Ohtsuka I.

J Nat Med. 2018 Dec 10. doi: 10.1007/s11418-018-1271-1. [Epub ahead of print]

PMID:
30535786
12.

Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development.

Chen Z, Liu F, Zheng N, Guo M, Bao L, Zhan Y, Zhang M, Zhao Y, Guo W, Ding G.

Biomed Pharmacother. 2019 Feb;110:285-293. doi: 10.1016/j.biopha.2018.11.069. Epub 2018 Dec 3.

13.

Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-κB Signalling Pathway.

Qin JH, Lin JR, Ding WF, Wu WH.

Inflammation. 2018 Dec 5. doi: 10.1007/s10753-018-0943-z. [Epub ahead of print]

PMID:
30519926
14.

Effects of Schisandra chinensis polysaccharides on rats with antibiotic-associated diarrhea.

Qi Y, Chen L, Gao K, Shao Z, Huo X, Hua M, Liu S, Sun Y, Li S.

Int J Biol Macromol. 2019 Mar 1;124:627-634. doi: 10.1016/j.ijbiomac.2018.11.250. Epub 2018 Nov 27.

PMID:
30500495
15.

Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from Schisandra chinensis.

Fu Q, Yang K, Hu RX, Du Z, Hu CM, Zhang X.

Xenobiotica. 2018 Nov 28:1-27. doi: 10.1080/00498254.2018.1548718. [Epub ahead of print]

PMID:
30486721
16.

Targeted Lignan Profiling and Anti-Inflammatory Properties of Schisandra rubriflora and Schisandra chinensis Extracts.

Szopa A, Dziurka M, Warzecha A, Kubica P, Klimek-Szczykutowicz M, Ekiert H.

Molecules. 2018 Nov 27;23(12). pii: E3103. doi: 10.3390/molecules23123103.

17.

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction.

Zhang YH, Zhao ZY, Wang BJ, Zhang YQ, Zhang M, Gao YY.

J Toxicol Environ Health A. 2018;81(24):1224-1230. doi: 10.1080/15287394.2018.1502561. Epub 2018 Nov 28.

PMID:
30485163
18.

Rapid and direct determination of fatty acids and glycerides profiles in Schisandra chinensis oil by using UPLC-Q/TOF-MSE.

Gao Y, Wu S, Feng L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 1;1104:157-167. doi: 10.1016/j.jchromb.2018.11.022. Epub 2018 Nov 19.

PMID:
30476796
19.
20.

Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder.

Tian J, Tang W, Xu M, Zhang C, Zhao P, Cao T, Shan X, Lu R, Guo W.

Cell Physiol Biochem. 2018;50(5):1726-1739. doi: 10.1159/000494791. Epub 2018 Nov 1.

Supplemental Content

Loading ...
Support Center